PART 1: SGLT2s as a Heart Failure Drug – How Did We Get Here?
- Discuss current SGLT2 data and guideline recommendations for utilization in heart failure
- Evaluate emerging data on the treatment of heart failure with SGLT2 inhibitors
- Understand the implications of emerging data on the treatment of heart failure with SGLT2 inhibitors for clinical practice.
This independent medical education symposium was supported by a grant from the Boehringer Ingelheim & Eli Lilly and Company alliance.